|
1
|
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.
|
Lancet Infect Dis
|
2010
|
2.67
|
|
2
|
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
|
Clin Infect Dis
|
2008
|
2.09
|
|
3
|
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.
|
J Infect Dis
|
2006
|
1.99
|
|
4
|
Severity of meningococcal disease associated with genomic bacterial load.
|
Clin Infect Dis
|
2009
|
1.92
|
|
5
|
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.
|
Thorax
|
2011
|
1.91
|
|
6
|
Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival.
|
AIDS
|
2002
|
1.79
|
|
7
|
Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice.
|
Respir Med
|
2004
|
1.76
|
|
8
|
Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis.
|
Arthritis Rheum
|
2008
|
1.73
|
|
9
|
Age-related loss of CpG methylation in the tumour necrosis factor promoter.
|
Cytokine
|
2011
|
1.58
|
|
10
|
Toll-like receptors in health and disease: complex questions remain.
|
J Immunol
|
2003
|
1.57
|
|
11
|
Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages.
|
Infect Immun
|
2002
|
1.53
|
|
12
|
Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
|
Clin Infect Dis
|
2006
|
1.51
|
|
13
|
Nitric oxide metabolism in Neisseria meningitidis.
|
J Bacteriol
|
2002
|
1.49
|
|
14
|
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.
|
Eur Respir J
|
2012
|
1.44
|
|
15
|
Management of meningitis.
|
Clin Med
|
2005
|
1.43
|
|
16
|
Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance.
|
J Clin Invest
|
2005
|
1.42
|
|
17
|
Nitric oxide in chemostat-cultured Escherichia coli is sensed by Fnr and other global regulators: unaltered methionine biosynthesis indicates lack of S nitrosation.
|
J Bacteriol
|
2006
|
1.42
|
|
18
|
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.
|
Thorax
|
2012
|
1.40
|
|
19
|
Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa.
|
Infect Immun
|
2005
|
1.37
|
|
20
|
Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice.
|
BMJ Open
|
2012
|
1.37
|
|
21
|
Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection.
|
FASEB J
|
2004
|
1.33
|
|
22
|
Interaction of the Salmonella typhimurium transcription and virulence factor SlyA with target DNA and identification of members of the SlyA regulon.
|
J Biol Chem
|
2002
|
1.32
|
|
23
|
Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load.
|
J Infect Dis
|
2003
|
1.28
|
|
24
|
Invasion by Neisseria meningitidis varies widely between clones and among nasopharyngeal mucosae derived from adult human hosts.
|
Microbiology
|
2002
|
1.17
|
|
25
|
Regulation of denitrification genes in Neisseria meningitidis by nitric oxide and the repressor NsrR.
|
J Bacteriol
|
2006
|
1.14
|
|
26
|
Neisseria meningitidis lactate permease is required for nasopharyngeal colonization.
|
Infect Immun
|
2005
|
1.11
|
|
27
|
The pathogen Neisseria meningitidis requires oxygen, but supplements growth by denitrification. Nitrite, nitric oxide and oxygen control respiratory flux at genetic and metabolic levels.
|
Mol Microbiol
|
2005
|
1.10
|
|
28
|
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains.
|
Infect Immun
|
2003
|
1.09
|
|
29
|
NsrR: a key regulator circumventing Salmonella enterica serovar Typhimurium oxidative and nitrosative stress in vitro and in IFN-gamma-stimulated J774.2 macrophages.
|
Microbiology
|
2007
|
1.08
|
|
30
|
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
|
J Infect
|
2010
|
1.06
|
|
31
|
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.
|
FASEB J
|
2011
|
1.05
|
|
32
|
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
|
Clin Infect Dis
|
2011
|
1.04
|
|
33
|
Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms.
|
Infect Immun
|
2006
|
1.04
|
|
34
|
Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis.
|
Lancet Infect Dis
|
2010
|
1.03
|
|
35
|
Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages.
|
J Leukoc Biol
|
2004
|
1.03
|
|
36
|
A cardinal role for cathepsin d in co-ordinating the host-mediated apoptosis of macrophages and killing of pneumococci.
|
PLoS Pathog
|
2011
|
1.02
|
|
37
|
Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.
|
J Infect Dis
|
2003
|
1.02
|
|
38
|
Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
|
Mol Immunol
|
2007
|
1.01
|
|
39
|
Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing.
|
AIDS
|
2007
|
1.01
|
|
40
|
The hmp gene encoding the NO-inducible flavohaemoglobin in Escherichia coli confers a protective advantage in resisting killing within macrophages, but not in vitro: links with swarming motility.
|
Gene
|
2007
|
1.01
|
|
41
|
Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease.
|
J Immunol
|
2010
|
1.01
|
|
42
|
Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages.
|
Microbes Infect
|
2007
|
0.99
|
|
43
|
Peroxynitrite toxicity in Escherichia coli K12 elicits expression of oxidative stress responses and protein nitration and nitrosylation.
|
J Biol Chem
|
2010
|
0.99
|
|
44
|
Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010.
|
Emerg Infect Dis
|
2011
|
0.98
|
|
45
|
Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin.
|
Blood
|
2005
|
0.97
|
|
46
|
Post-transcriptional regulation of bacterial motility by aconitase proteins.
|
Mol Microbiol
|
2004
|
0.96
|
|
47
|
Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses.
|
Infect Immun
|
2005
|
0.96
|
|
48
|
Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule 1 (CD54) by human alveolar epithelial cells.
|
J Infect Dis
|
2002
|
0.94
|
|
49
|
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
|
Clin Vaccine Immunol
|
2009
|
0.93
|
|
50
|
Human microbial challenge: the ultimate animal model.
|
Lancet Infect Dis
|
2012
|
0.93
|
|
51
|
Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis.
|
FASEB J
|
2009
|
0.92
|
|
52
|
Anti-adhesion methods as novel therapeutics for bacterial infections.
|
Expert Rev Anti Infect Ther
|
2012
|
0.91
|
|
53
|
Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease.
|
PLoS One
|
2011
|
0.91
|
|
54
|
Identification of meningococcal genes necessary for colonization of human upper airway tissue.
|
Infect Immun
|
2008
|
0.91
|
|
55
|
Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae.
|
J Infect Dis
|
2003
|
0.90
|
|
56
|
Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.
|
Clin Vaccine Immunol
|
2009
|
0.89
|
|
57
|
Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection.
|
PLoS Pathog
|
2012
|
0.88
|
|
58
|
Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data.
|
PLoS One
|
2012
|
0.87
|
|
59
|
Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.
|
Immunology
|
2009
|
0.87
|
|
60
|
The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection.
|
PLoS One
|
2012
|
0.87
|
|
61
|
Induction of pro-inflammatory cytokine release by human macrophages during exposure of Streptococcus pneumoniae to penicillin is influenced by minimum inhibitory concentration ratio.
|
Int J Antimicrob Agents
|
2005
|
0.87
|
|
62
|
Nitrosothiols in bacterial pathogens and pathogenesis.
|
Antioxid Redox Signal
|
2012
|
0.86
|
|
63
|
Genetic variation in pro-inflammatory cytokines and meningococcal sepsis.
|
Curr Opin Infect Dis
|
2010
|
0.86
|
|
64
|
Chemiluminescence quantification of NO and its derivatives in liquid samples.
|
Methods Enzymol
|
2008
|
0.85
|
|
65
|
Respiratory infections.
|
J Med Microbiol
|
2002
|
0.85
|
|
66
|
Reduced interleukin-8 response to Streptococcus pneumoniae by alveolar macrophages from adults with HIV/AIDS.
|
AIDS
|
2005
|
0.85
|
|
67
|
HIV-1 infection is associated with altered innate pulmonary immunity.
|
J Infect Dis
|
2005
|
0.84
|
|
68
|
Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease.
|
Iran J Allergy Asthma Immunol
|
2008
|
0.84
|
|
69
|
Analysis of nitric oxide-dependent antimicrobial actions in macrophages and mice.
|
Methods Enzymol
|
2008
|
0.84
|
|
70
|
Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae.
|
Mol Cell Proteomics
|
2011
|
0.84
|
|
71
|
Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.
|
Clin Vaccine Immunol
|
2008
|
0.84
|
|
72
|
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.
|
Clin Infect Dis
|
2011
|
0.83
|
|
73
|
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.
|
Clin Vaccine Immunol
|
2010
|
0.82
|
|
74
|
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells.
|
Infect Immun
|
2011
|
0.82
|
|
75
|
Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
|
Vaccine
|
2007
|
0.82
|
|
76
|
B-cell-T-cell activation and interaction in common variable immunodeficiency.
|
Hum Immunol
|
2010
|
0.81
|
|
77
|
Genetic susceptibility to meningococcal infection.
|
Expert Rev Anti Infect Ther
|
2013
|
0.81
|
|
78
|
Increased surface toll-like receptor 2 expression in superantigen shock.
|
Crit Care Med
|
2008
|
0.81
|
|
79
|
Adult survivors of invasive pneumococcal disease exhibit defective B cell function.
|
Clin Infect Dis
|
2011
|
0.81
|
|
80
|
Challenges for development of meningococcal vaccines in infants and children.
|
Expert Rev Vaccines
|
2011
|
0.80
|
|
81
|
Editorial commentary: Vancomycin for your mother, metronidazole for your mother-in-law.
|
J Infect
|
2007
|
0.80
|
|
82
|
Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway.
|
Microbes Infect
|
2006
|
0.79
|
|
83
|
An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic.
|
PLoS One
|
2013
|
0.78
|
|
84
|
Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.
|
Clin Vaccine Immunol
|
2010
|
0.78
|
|
85
|
The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniae.
|
Clin Vaccine Immunol
|
2013
|
0.78
|
|
86
|
Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
|
J Antimicrob Chemother
|
2006
|
0.77
|
|
87
|
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
|
Trials
|
2012
|
0.77
|
|
88
|
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
|
PLoS One
|
2012
|
0.77
|
|
89
|
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2004
|
0.77
|
|
90
|
Bacterial genomic detection within cerebrospinal fluid of patients with meningococcal disease is influenced by microbial and host characteristics.
|
Clin Infect Dis
|
2011
|
0.77
|
|
91
|
Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.
|
Immunology
|
2014
|
0.75
|
|
92
|
The nonpathogenic commensal Neisseria: friends and foes in infectious disease.
|
Curr Opin Infect Dis
|
2019
|
0.75
|
|
93
|
Using the NIHR Comprehensive Clinical Research Network for infectious diseases and microbiology research.
|
J Infect
|
2012
|
0.75
|